Gilead Sciences GILD
NASDAQ GILD
$144.80 -0.85 (-0.58%)
As of: Sep 10, 2026 · 3:59 PM EDT

Gilead Sciences (GILD) Exchange Rate Effect (2009 - 2026)

Gilead Sciences' (GILD) quarterly Exchange Rate Effect came in at -$19.0 million in Q2 2026, down 126.03% on a YoY basis from $73.0 million in Q2 2025, and down 72.73% quarter-over-quarter from -$11.0 million in Q1 2026.

Analysis

Gilead Sciences (GILD) Exchange Rate Effect (2009 - 2026) Analysis & Trends

Gilead Sciences (GILD) has reported Exchange Rate Effect for 18 consecutive years, with -$19.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Exchange Rate Effect fell 126.03% year-over-year to -$19.0 million; the trailing twelve-month figure through Jun 2026 stood at -$30.0 million (down 137.04% YoY), and the FY2025 full-year result was $92.0 million, up 330.0% from the prior year.
  • Exchange Rate Effect declined to -$19.0 million in Q2 2026 per GILD's latest filing, from -$11.0 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $75.0 million in Q4 2022 and bottomed at -$72.0 million in Q3 2022.
  • Historically, Exchange Rate Effect has averaged $888888.9 across 5 years, with a median of -$5.5 million in 2023.
  • The widest YoY moves for Exchange Rate Effect: up 933.33% in 2022, down 340.0% in 2022.
  • Over 5 years, Exchange Rate Effect stood at $75.0 million in 2022, then tumbled by 50.67% to $37.0 million in 2023, then sank by 248.65% to -$55.0 million in 2024, then soared by 109.09% to $5.0 million in 2025, then tumbled by 480.0% to -$19.0 million in 2026.
  • According to Business Quant data, Exchange Rate Effect over the past three periods registered -$19.0 million, -$11.0 million, and $5.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -19.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -3.70 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -300,000.00
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -2.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -2.45 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -3.40 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 315,000.00
10 Insmed 27.67 Bn 26.51 Bn 358.27 Mn -287,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -19.00 Mn
Mar 31, 2026 -11.00 Mn
Dec 31, 2025 5.00 Mn
Sep 30, 2025 -5.00 Mn
Jun 30, 2025 73.00 Mn
Mar 31, 2025 19.00 Mn
Dec 31, 2024 -55.00 Mn
Sep 30, 2024 44.00 Mn
Jun 30, 2024 -11.00 Mn
Mar 31, 2024 -18.00 Mn
Dec 31, 2023 37.00 Mn
Sep 30, 2023 -6.00 Mn
Jun 30, 2023 13.00 Mn
Mar 31, 2023 13.00 Mn
Dec 31, 2022 75.00 Mn
Sep 30, 2022 -72.00 Mn
Jun 30, 2022 -48.00 Mn
Mar 31, 2022 -18.00 Mn
Dec 31, 2021 -9.00 Mn
Sep 30, 2021 -23.00 Mn